Noyan Pajouhan biopharma

Noyan Pajouhan Biopharma is a specialized biotechnology company based in Iran that focuses on the development and manufacturing of high-tech recombinant proteins and biosimilars. The company primarily serves the therapeutic areas of hematology and endocrinology, providing critical treatments for conditions such as hemophilia and osteoporosis. Their product portfolio includes Noyafactor, a recombinant coagulation factor VIIa, and Noyapar, a biosimilar of teriparatide. Noyan Pajouhan Biopharma operates advanced manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. By focusing on complex biologics, the company aims to reduce reliance on expensive imported medicines and improve patient access to life-saving therapies in the MENA region.